{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:20:55Z","timestamp":1788520855331,"version":"build-2803163510"},"posted":{"date-parts":[[2025,10,20]]},"group-title":"Bioinformatics","reference-count":68,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["5R01AG072643"],"award-info":[{"award-number":["5R01AG072643"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["U24NS072026"],"award-info":[{"award-number":["U24NS072026"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["P30AG019610"],"award-info":[{"award-number":["P30AG019610"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["P30AG072980"],"award-info":[{"award-number":["P30AG072980"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007306","name":"Arizona Department of Health Services","doi-asserted-by":"crossref","award":["contract 211002"],"award-info":[{"award-number":["contract 211002"]}],"id":[{"id":"10.13039\/100007306","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"crossref","award":["contract 4001"],"award-info":[{"award-number":["contract 4001"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"crossref","award":["contract 0011"],"award-info":[{"award-number":["contract 0011"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"crossref","award":["contract 05-901"],"award-info":[{"award-number":["contract 05-901"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"crossref","award":["contract 1001"],"award-info":[{"award-number":["contract 1001"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Michael J. Fox Foundation for Parkinson\u2019s Researc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cognitive resilience to Alzheimer\u2019s disease (AD) pathology is associated with preserved expression of NPTX2, an activity-regulated synaptic protein involved in circuit plasticity, excitation\u2013inhibition balance, and complement-linked synapse regulation. However, the broader molecular programs coordinated with NPTX2 in resilient individuals remain unclear.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analyzed postmortem middle temporal gyrus tissue using targeted PRM-MS proteomics in 135 individuals and bulk RNA-seq in an expanded 575-sample cohort. NPTX2-associated molecular coordination was assessed within cognitively normal low-pathology controls (CN-Lo), cognitively normal high-pathology controls (CN-Hi), mild cognitive impairment (MCI), and AD. Correlation-based approaches were applied using NPTX2 protein and NPTX2 mRNA expression as anchors to define resilience mechanisms in CN-Hi subjects.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    NPTX2 protein abundance was preserved across all controls regardless of age and pathology but reduced in MCI and AD. NPTX2 mRNA expression was also invariant across pathology within controls and reduced in MCI and AD but decreased markedly with age. Targeted proteomics identified NPTX2 relationships with synaptic and inhibitory-circuit proteins that were preserved across control groups, alongside CN-Hi-specific recruitment of trafficking, lysosomal, metabolic, and proteostasis-associated proteins. Transcriptome-wide correlations with NPTX2 revealed differences in gene co-expression between groups, identifying a prominent activity-dependent program including BDNF, VGF, SCG2, SST, SERTM1, DUSP4, and EGR4, that was preserved in both CN-Lo and CN-Hi subjects, while genes recruited to the NPTX2 network specifically in CN-Hi implicated immune, neuroprotective, translation, and proteostasis-related pathways. Coupling differential gene expression analysis with co-expression, we further identified five candidate resilience genes whose expression and NPTX correlation was preserved across controls, but lost in MCI and AD: SST, MAL2, TAC1, SERTM1, and RFK. Expression of genes in distinct NPTX2 co-expression classes can be freely explored in our bulk RNA-seq data and other public AD transcriptomic datasets at\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/nemoanalytics.org\/landing\/neurodegeneration\/\">NeMO Analytics<\/jats:ext-link>\n                    .\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Findings suggest that cognitive resilience in the context of AD neuropathology engages a coordinated molecular state distinct from both persevered cognition without pathology and MCI\/AD, which is organized around preserved and selectively remodeled NPTX2-associations. Rather than reflecting broad transcript abundance changes, resilience was characterized by maintained synaptic and inhibitory programs, and adaptive proteostasis and trafficking pathways that distinguish resilient high-pathology individuals from low-pathology controls or symptomatic AD.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.10.17.683150","type":"posted-content","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T13:45:13Z","timestamp":1760967913000},"source":"Crossref","is-referenced-by-count":4,"title":["NPTX2-Centered Cognitive Resilience Mechanisms in the Context of AD Pathology"],"prefix":"10.64898","author":[{"given":"Yuelin","family":"Lao","sequence":"first","affiliation":[{"name":"Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Fang","family":"Xiao","sequence":"additional","affiliation":[{"name":"Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Ji","sequence":"additional","affiliation":[{"name":"Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio S.","family":"Piras","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungdo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bonfitto","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Song","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arailym","family":"Aldabergenova","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Hyun","family":"Na","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Sloan","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Trejo","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changiz","family":"Geula","sequence":"additional","affiliation":[{"name":"Mesulam Center for Cognitive Neurology & Alzheimer\u2019s Disease, Northwestern University School of Medicine, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Rogalski","sequence":"additional","affiliation":[{"name":"Healthy Aging & Alzheimer\u2019s Research Care (HAARC) Center, University of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia H.","family":"Kawas","sequence":"additional","affiliation":[{"name":"University of California, Irvine, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Corrada","sequence":"additional","affiliation":[{"name":"University of California, Irvine, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geidy E.","family":"Serrano","sequence":"additional","affiliation":[{"name":"Banner Sun Health Research Institute, Sun City, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Beach","sequence":"additional","affiliation":[{"name":"Banner Sun Health Research Institute, Sun City, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Troncoso","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Huentelman","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Barnes","sequence":"additional","affiliation":[{"name":"Evelyn F. McKnight Brain Institute, University of Arizona, Tucson, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Worley","sequence":"additional","affiliation":[{"name":"Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Colantuoni","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"Institute for Genome Sciences & Department of Neurology, University of Maryland, Baltimore, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026063013551636000_2025.10.17.683150v3.1","doi-asserted-by":"crossref","unstructured":"Chang, M.C. , et al., Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons , in Nat Neurosci. 2010: United States. p. 1090\u20137.","DOI":"10.1038\/nn.2621"},{"key":"2026063013551636000_2025.10.17.683150v3.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2015.02.020"},{"key":"2026063013551636000_2025.10.17.683150v3.3","unstructured":"Xiao, M.F. , et al., NPTX2 and cognitive dysfunction in Alzheimer\u2019s Disease. Elife, 2017. 6."},{"key":"2026063013551636000_2025.10.17.683150v3.4","doi-asserted-by":"crossref","unstructured":"Driscoll, I. and J. Troncoso , Asymptomatic Alzheimer\u2019s disease: a prodrome or a state of resilience?, in Curr Alzheimer Res. 2011: United Arab Emirates. p. 330\u20135.","DOI":"10.2174\/156720511795745348"},{"key":"2026063013551636000_2025.10.17.683150v3.5","doi-asserted-by":"crossref","unstructured":"Maarouf, C.L. , et al., Alzheimer\u2019s disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging, in PLoS One. 2011: United States. p. e27291.","DOI":"10.1371\/journal.pone.0027291"},{"key":"2026063013551636000_2025.10.17.683150v3.6","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e31825018f7"},{"key":"2026063013551636000_2025.10.17.683150v3.7","doi-asserted-by":"crossref","unstructured":"Buchman, A.S. , et al., Glycoproteome-Wide Discovery of Cortical Glycoproteins That May Provide Cognitive Resilience in Older Adults, in Neurology. 2024: United States. p. e209223.","DOI":"10.1212\/WNL.0000000000209223"},{"key":"2026063013551636000_2025.10.17.683150v3.8","doi-asserted-by":"crossref","unstructured":"Galasko, D. , et al., Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer\u2019s disease , in Alzheimers Dement (N Y). 2019: United States. p. 871\u2013882.","DOI":"10.1016\/j.trci.2019.11.002"},{"key":"2026063013551636000_2025.10.17.683150v3.9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26725"},{"key":"2026063013551636000_2025.10.17.683150v3.10","doi-asserted-by":"crossref","unstructured":"Oh, H.S. , et al., A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer\u2019s disease , in Nat Med. 2025: United States. p. 1592\u20131603.","DOI":"10.1038\/s41591-025-03565-2"},{"key":"2026063013551636000_2025.10.17.683150v3.11","doi-asserted-by":"crossref","first-page":"102746","DOI":"10.1016\/j.pneurobio.2025.102746","article-title":"NPTX2 transfection improves synaptic E\/I balance and performance in learning impaired aged rats","volume":"247","year":"2025","journal-title":"Prog Neurobiol"},{"key":"2026063013551636000_2025.10.17.683150v3.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2025.04.010"},{"key":"2026063013551636000_2025.10.17.683150v3.13","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-08-02463.1996"},{"key":"2026063013551636000_2025.10.17.683150v3.14","doi-asserted-by":"crossref","unstructured":"Xu, D. , et al., Narp and NP1 form heterocomplexes that function in developmental and activity-dependent synaptic plasticity, in Neuron. 2003: United States. p. 513\u201328.","DOI":"10.1016\/S0896-6273(03)00463-X"},{"key":"2026063013551636000_2025.10.17.683150v3.15","doi-asserted-by":"crossref","unstructured":"Xiao, M.F. , et al., A biomarker-authenticated model of schizophrenia implicating NPTX2 loss of function, in Sci Adv. 2021: United States. p. eabf6935.","DOI":"10.1126\/sciadv.abf6935"},{"key":"2026063013551636000_2025.10.17.683150v3.16","doi-asserted-by":"crossref","unstructured":"Sia, G.M. , et al., Interaction of the N-terminal domain of the AMPA receptor GluR4 subunit with the neuronal pentraxin NP1 mediates GluR4 synaptic recruitment, in Neuron. 2007: United States. p. 87\u2013102.","DOI":"10.1016\/j.neuron.2007.06.020"},{"key":"2026063013551636000_2025.10.17.683150v3.17","doi-asserted-by":"crossref","unstructured":"Zhou, J. , et al., The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration. Sci Transl Med, 2023. 15(689): p. eadf0141.","DOI":"10.1126\/scitranslmed.adf0141"},{"key":"2026063013551636000_2025.10.17.683150v3.18","doi-asserted-by":"publisher","DOI":"10.1111\/neup.12189"},{"key":"2026063013551636000_2025.10.17.683150v3.19","doi-asserted-by":"crossref","unstructured":"Beach, T.G. , et al., The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007, in Cell Tissue Bank. 2008: Netherlands. p. 229\u201345.","DOI":"10.1007\/s10561-008-9067-2"},{"key":"2026063013551636000_2025.10.17.683150v3.20","doi-asserted-by":"publisher","DOI":"10.1007\/s10561-010-9210-8"},{"key":"2026063013551636000_2025.10.17.683150v3.21","doi-asserted-by":"crossref","unstructured":"Walker, D.G. , et al., Characterization of RNA isolated from eighteen different human tissues: results from a rapid human autopsy program , in Cell Tissue Bank. 2016: Netherlands. p. 361\u201375.","DOI":"10.1007\/s10561-016-9555-8"},{"key":"2026063013551636000_2025.10.17.683150v3.22","doi-asserted-by":"crossref","unstructured":"Corrada, M.M. , D.J. Berlau , and C.H. Kawas , A population-based clinicopathological study in the oldest-old: the 90+ study, in Curr Alzheimer Res. 2012: United Arab Emirates. p. 709\u201317.","DOI":"10.2174\/156720512801322537"},{"key":"2026063013551636000_2025.10.17.683150v3.23","doi-asserted-by":"crossref","unstructured":"Whittle, C. , et al., Neuropsychological data in nondemented oldest old: the 90+ Study, in J Clin Exp Neuropsychol. 2007: England. p. 290\u20139.","DOI":"10.1080\/13803390600678038"},{"key":"2026063013551636000_2025.10.17.683150v3.24","doi-asserted-by":"crossref","unstructured":"Corrada, M.M. , et al., Prevalence of dementia after age 90: results from the 90+ study, in Neurology. 2008: United States. p. 337\u201343.","DOI":"10.1212\/01.wnl.0000310773.65918.cd"},{"key":"2026063013551636000_2025.10.17.683150v3.25","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21915"},{"key":"2026063013551636000_2025.10.17.683150v3.26","doi-asserted-by":"publisher","DOI":"10.1162\/jocn_a_00300"},{"key":"2026063013551636000_2025.10.17.683150v3.27","unstructured":"Rogalski, E.J. , et al., The Multisite SuperAging Research Initiative: Enrollment and Scientific Progress. Alzheimer\u2019s & Dementia, 2024. 20(S3)."},{"key":"2026063013551636000_2025.10.17.683150v3.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2018.07.007"},{"key":"2026063013551636000_2025.10.17.683150v3.29","doi-asserted-by":"crossref","unstructured":"Di Tommaso, P. , et al., Nextflow enables reproducible computational workflows, in Nat Biotechnol. 2017: United States. p. 316\u2013319.","DOI":"10.1038\/nbt.3820"},{"key":"2026063013551636000_2025.10.17.683150v3.30","doi-asserted-by":"crossref","unstructured":"Dobin, A. , et al., STAR: ultrafast universal RNA-seq aligner , in Bioinformatics. 2013: England. p. 15\u201321.","DOI":"10.1093\/bioinformatics\/bts635"},{"key":"2026063013551636000_2025.10.17.683150v3.31","doi-asserted-by":"crossref","unstructured":"Patro, R. , et al., Salmon provides fast and bias-aware quantification of transcript expression , in Nat Methods. 2017: United States. p. 417\u2013419.","DOI":"10.1038\/nmeth.4197"},{"key":"2026063013551636000_2025.10.17.683150v3.32","doi-asserted-by":"crossref","unstructured":"Ewels, P. , et al., MultiQC: summarize analysis results for multiple tools and samples in a single report , in Bioinformatics. 2016: England. p. 3047\u20138.","DOI":"10.1093\/bioinformatics\/btw354"},{"key":"2026063013551636000_2025.10.17.683150v3.33","doi-asserted-by":"crossref","unstructured":"Okonechnikov, K. , A. Conesa , and F. Garcia-Alcalde , Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data, in Bioinformatics. 2016: England. p. 292\u20134.","DOI":"10.1093\/bioinformatics\/btv566"},{"key":"2026063013551636000_2025.10.17.683150v3.34","doi-asserted-by":"crossref","unstructured":"34. Love, M.I. , W. Huber , and S. Anders , Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, in Genome Biol. 2014: England. p. 550.","DOI":"10.1101\/002832"},{"key":"2026063013551636000_2025.10.17.683150v3.35","doi-asserted-by":"crossref","unstructured":"Jang, Y. , et al., Mass spectrometry-based proteomics analysis of human globus pallidus from progressive supranuclear palsy patients discovers multiple disease pathways, in Clin Transl Med. 2022: United States. p. e1076.","DOI":"10.1002\/ctm2.1076"},{"key":"2026063013551636000_2025.10.17.683150v3.36","doi-asserted-by":"crossref","unstructured":"36. MacLean, B. , et al., Skyline: an open source document editor for creating and analyzing targeted proteomics experiments, in Bioinformatics. 2010: England. p. 966\u20138.","DOI":"10.1093\/bioinformatics\/btq054"},{"key":"2026063013551636000_2025.10.17.683150v3.37","doi-asserted-by":"crossref","unstructured":"Lin, W.J. , et al., VGF and Its C-Terminal Peptide TLQP-62 Regulate Memory Formation in Hippocampus via a BDNF-TrkB-Dependent Mechanism, in J Neurosci. 2015: United States. p. 10343\u201356.","DOI":"10.1523\/JNEUROSCI.0584-15.2015"},{"key":"2026063013551636000_2025.10.17.683150v3.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.07.010"},{"key":"2026063013551636000_2025.10.17.683150v3.39","doi-asserted-by":"crossref","unstructured":"Ohrfelt, A. , et al., The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer\u2019s disease, in Alzheimers Res Ther. 2016: England. p. 41.","DOI":"10.1186\/s13195-016-0208-8"},{"key":"2026063013551636000_2025.10.17.683150v3.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.12.015"},{"key":"2026063013551636000_2025.10.17.683150v3.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.09.050"},{"key":"2026063013551636000_2025.10.17.683150v3.42","doi-asserted-by":"crossref","unstructured":"Geissler, R. , et al., A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2\/B1, in Genes Dev. 2016: United States. p. 1070\u201385.","DOI":"10.1101\/gad.277392.116"},{"key":"2026063013551636000_2025.10.17.683150v3.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2020.11.002"},{"key":"2026063013551636000_2025.10.17.683150v3.44","doi-asserted-by":"crossref","unstructured":"Jiang, Y. , et al., Functional human GRIN2B promoter polymorphism and variation of mental processing speed in older adults, in Aging (Albany NY). 2017: United States. p. 1293\u20131306.","DOI":"10.18632\/aging.101228"},{"key":"2026063013551636000_2025.10.17.683150v3.45","doi-asserted-by":"crossref","unstructured":"Schoch, S. , et al., RIM1alpha forms a protein scaffold for regulating neurotransmitter release at the active zone, in Nature. 2002: England. p. 321\u20136.","DOI":"10.1038\/415321a"},{"key":"2026063013551636000_2025.10.17.683150v3.46","doi-asserted-by":"crossref","unstructured":"Powell, C.M. , et al., The presynaptic active zone protein RIM1alpha is critical for normal learning and memory, in Neuron. 2004: United States. p. 143\u201353.","DOI":"10.1016\/S0896-6273(04)00146-1"},{"key":"2026063013551636000_2025.10.17.683150v3.47","doi-asserted-by":"crossref","unstructured":"Blundell, J. , et al., RIM1alpha and interacting proteins involved in presynaptic plasticity mediate prepulse inhibition and additional behaviors linked to schizophrenia, in J Neurosci. 2010: United States. p. 5326\u201333.","DOI":"10.1523\/JNEUROSCI.0328-10.2010"},{"key":"2026063013551636000_2025.10.17.683150v3.48","doi-asserted-by":"crossref","unstructured":"Wingo, A.P. , et al., Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age, in Nat Commun. 2019: England. p. 1619.","DOI":"10.1038\/s41467-019-09613-z"},{"key":"2026063013551636000_2025.10.17.683150v3.49","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00460"},{"key":"2026063013551636000_2025.10.17.683150v3.50","doi-asserted-by":"crossref","unstructured":"Cacace, R. , et al., Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability, in Acta Neuropathol. 2019: Germany. p. 901\u2013918.","DOI":"10.1007\/s00401-019-01976-3"},{"key":"2026063013551636000_2025.10.17.683150v3.51","doi-asserted-by":"crossref","first-page":"111922","DOI":"10.1016\/j.bbr.2019.111922","article-title":"Increased seizure sensitivity, emotional defects and cognitive impairment in PHD finger protein 24 (Phf24)-null rats","volume":"369","year":"2019","journal-title":"Behav Brain Res"},{"key":"2026063013551636000_2025.10.17.683150v3.52","doi-asserted-by":"crossref","unstructured":"Urdanoz-Casado, A. , et al., Gender-Dependent Deregulation of Linear and Circular RNA Variants of HOMER1 in the Entorhinal Cortex of Alzheimer\u2019s Disease, in Int J Mol Sci. 2021: Switzerland.","DOI":"10.3390\/ijms22179205"},{"key":"2026063013551636000_2025.10.17.683150v3.53","doi-asserted-by":"crossref","unstructured":"Park, H. and M.M. Poo , Neurotrophin regulation of neural circuit development and function , in Nat Rev Neurosci. 2013: England. p. 7\u201323.","DOI":"10.1038\/nrn3379"},{"key":"2026063013551636000_2025.10.17.683150v3.54","doi-asserted-by":"crossref","unstructured":"Selten, M. , et al., Regulation of PV interneuron plasticity by neuropeptide-encoding genes , in Nature. 2025: England. p. 173\u2013181.","DOI":"10.1038\/s41586-025-08933-z"},{"key":"2026063013551636000_2025.10.17.683150v3.55","doi-asserted-by":"crossref","unstructured":"Urban-Ciecko, J. and A.L. Barth , Somatostatin-expressing neurons in cortical networks, in Nat Rev Neurosci. 2016: England. p. 401\u20139.","DOI":"10.1038\/nrn.2016.53"},{"key":"2026063013551636000_2025.10.17.683150v3.56","doi-asserted-by":"crossref","unstructured":"de Marco, M.C. , et al., MAL2, a novel raft protein of the MAL family, is an essential component of the machinery for transcytosis in hepatoma HepG2 cells, in J Cell Biol. 2002: United States. p. 37\u201344.","DOI":"10.1083\/jcb.200206033"},{"key":"2026063013551636000_2025.10.17.683150v3.57","doi-asserted-by":"crossref","unstructured":"Zou, Y. , et al., Neuroprotective effect of riboflavin kinase on cerebral ischemia injury in rats , in Mol Med. 2025: England. p. 125.","DOI":"10.1186\/s10020-025-01170-0"},{"key":"2026063013551636000_2025.10.17.683150v3.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2025.09.002"},{"key":"2026063013551636000_2025.10.17.683150v3.59","unstructured":"Gabitto, M.I. , et al., Integrated multimodal cell atlas of Alzheimer\u2019s disease, in Nat Neurosci. 2024: United States. p. 2366\u20132383."},{"key":"2026063013551636000_2025.10.17.683150v3.60","doi-asserted-by":"publisher","DOI":"10.1111\/neup.12649"},{"key":"2026063013551636000_2025.10.17.683150v3.61","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)70016-5"},{"key":"2026063013551636000_2025.10.17.683150v3.62","doi-asserted-by":"crossref","unstructured":"Hipp, M.S. , P. Kasturi , and F.U. Hartl , The proteostasis network and its decline in ageing , in Nat Rev Mol Cell Biol. 2019: England. p. 421\u2013435.","DOI":"10.1038\/s41580-019-0101-y"},{"key":"2026063013551636000_2025.10.17.683150v3.63","unstructured":"Beckmann, N.D. , et al., Multiscale causal networks identify VGF as a key regulator of Alzheimer\u2019s disease , in Nat Commun. 2020: England. p. 3942."},{"key":"2026063013551636000_2025.10.17.683150v3.64","doi-asserted-by":"crossref","unstructured":"Quinn, J.P. , et al., VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases, in Brain Commun. 2021: England. p. fcab261.","DOI":"10.1093\/braincomms\/fcab261"},{"key":"2026063013551636000_2025.10.17.683150v3.65","doi-asserted-by":"crossref","unstructured":"Nixon, R.A ., Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer\u2019s disease: inseparable partners in a multifactorial disease , in FASEB J. 2017: United States. p. 2729\u20132743.","DOI":"10.1096\/fj.201700359"},{"key":"2026063013551636000_2025.10.17.683150v3.66","doi-asserted-by":"crossref","unstructured":"Arenaza-Urquijo, E.M. and P. Vemuri , Resistance vs resilience to Alzheimer disease: Clarifying terminology for preclinical studies , in Neurology. 2018: United States. p. 695\u2013703.","DOI":"10.1212\/WNL.0000000000005303"},{"key":"2026063013551636000_2025.10.17.683150v3.67","doi-asserted-by":"crossref","unstructured":"Mathys, H. , et al., Single-cell transcriptomic analysis of Alzheimer\u2019s disease , in Nature. 2019: England. P. 332\u2013337.","DOI":"10.1038\/s41586-019-1195-2"},{"key":"2026063013551636000_2025.10.17.683150v3.68","doi-asserted-by":"crossref","unstructured":"Piras, I.S. , et al., Transcriptomic profiling of the middle temporal gyrus reveals differential glial\/neuronal dysregulation across Alzheimer\u2019s disease and aging. bioRxiv, 2025.","DOI":"10.1101\/2025.10.19.683343"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.10.17.683150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:33:38Z","timestamp":1782855218000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.10.17.683150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":68,"URL":"https:\/\/doi.org\/10.1101\/2025.10.17.683150","relation":{},"subject":[],"published":{"date-parts":[[2025,10,20]]},"subtype":"preprint"}}